Adtalem Global Education (ATGE)
(Delayed Data from NYSE)
$75.37 USD
-0.11 (-0.15%)
Updated Oct 1, 2024 04:00 PM ET
After-Market: $75.33 -0.04 (-0.05%) 7:58 PM ET
3-Hold of 5 3
A Value B Growth C Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$75.37 USD
-0.11 (-0.15%)
Updated Oct 1, 2024 04:00 PM ET
After-Market: $75.33 -0.04 (-0.05%) 7:58 PM ET
3-Hold of 5 3
A Value B Growth C Momentum A VGM
Zacks News
Can Adtalem (ATGE) Run Higher on Rising Earnings Estimates?
by Zacks Equity Research
Adtalem (ATGE) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
American Public (APEI) Q1 Earnings & Revenues Lag Estimates
by Zacks Equity Research
American Public Education's (APEI) first-quarter results reflect the inclusion of RU and an increase in student enrollment at HCN. Higher costs pose as risks.
ATGE or PWSC: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
ATGE vs. PWSC: Which Stock Is the Better Value Option?
Can Adtalem (ATGE) Climb 44% to Reach the Level Wall Street Analysts Expect?
by Zacks Equity Research
The mean of analysts' price targets for Adtalem (ATGE) points to a 44% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Adtalem (ATGE) Lags on Q3 Earnings, Ups FY22 Adjusted EPS View
by Zacks Equity Research
Adtalem Global Education's (ATGE) third-quarter fiscal 2021 results are hurt by COVID-related headwinds.
Adtalem Global Education (ATGE) Lags Q3 Earnings Estimates
by Zacks Equity Research
Adtalem (ATGE) delivered earnings and revenue surprises of -1.14% and 0.86%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Grand Canyon Education (LOPE) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Grand Canyon Education (LOPE) delivered earnings and revenue surprises of 1.18% and 0.88%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Bright Horizons Family Solutions (BFAM) Beats Q1 Earnings Estimates
by Zacks Equity Research
Bright Horizons (BFAM) delivered earnings and revenue surprises of 14.63% and 3.06%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Adtalem (ATGE) Down 3.2% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Adtalem (ATGE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
American Public (APEI) Q4 Earnings Top Estimates, Guidance Tepid
by Zacks Equity Research
American Public Education's (APEI) fourth-quarter results reflect the inclusion of RU and increase in student enrollment at HCN.
Strategic Education (STRA) Q4 Earnings Top, USHE Enrollment Low
by Zacks Equity Research
Strategic Education's (STRA) results for fourth-quarter 2021 are hurt by USHE softness.
New Strong Sell Stocks for February 15th
by Zacks Equity Research
ATGE, ALGN, and APDN have been added to the Zacks Rank #5 (Strong Sell) List on February 15, 2022
Mohawk's (MHK) Q4 Earnings and Sales Beat, Q1 View Tepid
by Zacks Equity Research
Mohawk Industries' (MHK) fourth-quarter results benefit from solid residential demand.
Adtalem (ATGE) Q2 Earnings Lag, Stock Dips on Tepid FY22 View
by Zacks Equity Research
Adtalem Global Education's (ATGE) results for second-quarter fiscal 2021 are hurt by COVID-related headwinds.
Universal Technical Institute (UTI) Beats Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Universal Technical (UTI) delivered earnings and revenue surprises of 2,600% and 8.89%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Adtalem Global Education (ATGE) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Adtalem (ATGE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Adtalem (ATGE) Up on Financial Services Unit Sale Announcement
by Zacks Equity Research
Adtalem Global Education (ATGE) to meet the rapidly growing and unmet demand for healthcare professionals in the United States.
Why Is Adtalem (ATGE) Down 6.1% Since Last Earnings Report?
by Zacks Equity Research
Adtalem (ATGE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Adtalem (ATGE) Q1 Earnings & Revenues Miss on Lower Enrollment
by Zacks Equity Research
Adtalem Global Education (ATGE) reports lower-than-expected first-quarter fiscal 2022 results owing to reduced enrollments and higher costs.
Adtalem Global Education (ATGE) Q1 Earnings and Revenues Lag Estimates
by Zacks Equity Research
Adtalem (ATGE) delivered earnings and revenue surprises of -16.22% and -0.95%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Adtalem Global Education (ATGE) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Adtalem (ATGE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Adtalem's (ATGE) Chamberlain Partners Emory for Nursing
by Zacks Equity Research
Adtalem Global Education (ATGE) and Emory are set to encourage eligible nurses to address nursing shortages.
ATGE vs. BFAM: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
ATGE vs. BFAM: Which Stock Is the Better Value Option?
Adtalem (ATGE) Rallies 43% in the Past Year: More Room to Run?
by Zacks Equity Research
Adtalem (ATGE) has been benefiting from the inclusion of Walden University, robust demand for OnCourse learning, and introduction of evening and weekend classes.
All You Need to Know About Adtalem (ATGE) Rating Upgrade to Strong Buy
by Zacks Equity Research
Adtalem (ATGE) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.